Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » NanoCellect Biomedical Receives $1.5M NIH Grant to Develop 3D Flow Cytometry Tool

NanoCellect Biomedical Receives $1.5M NIH Grant to Develop 3D Flow Cytometry Tool

Oct 04, 2019
|
staff reporter

NEW YORK – NanoCellect Biomedical said today that the National Institutes of Health has awarded the firm a $1.5 million Phase II Small Business Innovation Research grant to further develop its imaging flow cytometry technology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Vaccine Supply Chain Hacker Warning

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

Illinois Cuts Forensic Testing Backlog

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

Lying Plea

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

Science Studies on Nonalcoholic Fatty Liver Disease Expression Signatures, Ties Between Gut Microbiome and Major Depression

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.

What's Popular?

In Business News

  1. Ravgen Sues Illumina, Roche Alleging Infringement of Cell-Free DNA Testing Patents

  2. Proteomics Firm Seer Prices $175M IPO

  3. Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing

  4. Swedish Sequencing Firm Single Technologies Raises $6.1M

  5. Aetna Updates Noninvasive Prenatal Testing Coverage Policy to Include All Pregnancies

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.